Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04295382 · ClinicalTrials.gov registry record · NA
Feasibility Study of a Software Application for Patients Hospitalized After Suicidal Ideation or Suicide Attempts
A NA study, sponsored by Oui Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04295382 is a NA study that has completed, run by Oui Therapeutics. The registered enrollment target is 15 participants.
The verdict
NCT04295382, a NA study, has completed, sponsored by Oui Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The primary objective of this feasibility study is to assess the feasibility, and usability of a software application to deliver targeted interactive exercises to patients recently hospitalized for suicidal ideation or suicide attempts.
Interventions
- DEVICE Software Application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-05-12 |
| Est. Completion | 2021-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04295382
The ClinicalTrials.gov registry entry for NCT04295382 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oui Therapeutics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Software Application is the first listed.
NCT04295382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04295382 about?
NCT04295382 is a clinical study titled "Feasibility Study of a Software Application for Patients Hospitalized After Suicidal Ideation or Suicide Attempts". The primary objective of this feasibility study is to assess the feasibility, and usability of a software application to deliver targeted interactive exercises to patients recently hospitalized for suicidal ideation or suicide attempts.
What is the current status of trial NCT04295382?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2020-05-12. Estimated completion is 2021-07-01.
What interventions are being tested in trial NCT04295382?
The interventions under investigation include: Software Application (DEVICE).
Who is sponsoring clinical trial NCT04295382?
This trial is sponsored by Oui Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.